Laceration Closure Devices Market is Segmented By Product(Staples, Hemostats, Adhesives, Sutures, Strips, Sealants, Wound Strips, Mechanical Wound Closure Devices), By Wound Type(Acute, Chronic, Burns, Ulcers, Surgical Wounds, Others), By End-User(Hospitals, Ambulatory Surgery Centers, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023- 2030.
Laceration Closure Devices Market size was valued US$ YY million in 2020 and is estimated to reach US$ YY million by 2028, and register a revenue CAGR 8.8% during the forecast period (2023- 2030).
Report Scope
| Metrics | Details |
| Market CAGR | 8.8% |
| Segments Covered | By Product, By Wound Type, By End-User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
Market Dynamics
Technological advancements in laceration closure devices are expected to drive the market's growth.
The DermaClip Skin Closure Device is a novel, non-invasive, painless, and simple-to-use wound closure device that eliminates the need for needles or harsh anesthetic injections, as well as causing additional damage to the injured area. The DermaClip device's efficacy in addressing the needs of clinical applications was established in a trial. In addition, no adverse occurrences occurred throughout the product safety test. The device's efficacy, combined with its ease of use and minimal application requirements, make it a wound closure device that is particularly useful in emergency and battlefield situations.
Driver:
Trauma, burns, accidents, and sports-related injuries are all rising. Increasing use of technology in cosmetic or plastic operations, rising disability rates, an ageing population, an increase in the number of surgical procedures, rising incidence of infectious and non-communicable diseases are some of the factors the market is expected to drive in the forecast period.
Side effects of laceration closure devices are expected to hamper the market's growth.
According to the American Academy of Opthalmology, treating canalicular lacerations with surgical repair has resulted in pain, bleeding, infection, vision loss (though this is extremely rare), scarring (or poor healing). Moreover, the canalicular laceration healing failure may result in nasolacrimal duct drainage problems. For instance, dog bites are a common source of canalicular lacerations due to their propensity for occurring around the medial canthus, as are blunt shear injuries.
COVID-19 Impact Analysis
The Covid-19 crisis has impacted all medical professionals. Because of the novel coronavirus (COVID-19, SARS-COV-2) outbreak, practice guidelines constantly change. To save personal protective equipment and limit patient and physician exposure, many state and consensus guidelines propose limiting non-urgent operations and patient interaction. Furthermore, doctors attempted to employ wound closure technologies to provide adequate support for wounds while reducing direct contact with patients. For instance, cutaneous absorbable sutures or fast-absorbing gut sutures are good options for minor injuries. A more lasting superficial closure approach for more significant wounds would not fail prematurely. The patient could be easily removed at home using an ARS device (adhesive retention suture).
Additionally, the pandemic is interrupting the supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.
Segmentation Analysis
The adhesive segment is expected to hold the largest laceration closure devices market share.
The adhesive segment accounted for the largest market share in 2020. According to the American Association and Hip and Knee Surgeons, the skin-adhesive most commonly used Dermabond Advanced (DBA) is a 2-octyl-cyanoacrylate-based liquid skin adhesive. It's been around for a long time and has a lot of benefits. It's simple to work with and apply to the skin's surface. When compared to traditional suturing, faster and stronger skin closure is obtained. It also serves as a barrier against microorganisms that could cause infection.
Moreover, because DBA is waterproof, patients can shower right after surgery. There are no sutures to take out, which is beneficial for tiny children. DBA is thought to provide similar results as standard suture closure in cosmetic results. Therefore, the market is expected to boost in the forecast period from the above statements.
Chronic Wound segments are expected to hold the largest laceration closure devices market share.
The chronic wound segment accounted for the largest market share in 2020. Chronic wounds, such as pressure ulcers, diabetic ulcers, venous ulcers, and arterial insufficiency ulcers, are lesions that fail to progress through the normal healing process within 12 weeks. Moreover, the treatment of skin chronic wounds still serves as a significant challenge. Wound medical devices (MDs) range from conventional and advanced dressings to skin grafts, but none of these is generally recognized as a gold standard. Based on recent developments, nanotechnology-based medical devices are intended as skin substitutes. In particular, nanofibrous scaffolds are promising platforms for wound healing, primarily due to their similarity to the extracellular matrix (ECM) and their capability to promote cell adhesion and proliferation and restore skin integrity when grafted into the wound site. Therefore, the chronic wound segment holds the largest market share from the above statements.
Geographical Analysis
North America region holds the largest market share of the global laceration closure devices market.
In 2020, North America accounted for the highest revenue share. The market is predicted to grow because of several factors: the easy availability of new techniques and technology, a well-established medical and healthcare infrastructure, and increased opportunities for the region's leading players. For instance, Ms. Taylor, a 17-year-old student from Iowa, has developed a groundbreaking new suture that changes color when surgical wounds become infected. This feature can warn physicians and aid in preventing potentially dangerous infections. Antibacterial properties have been reported for beets. The girl dyed various suture materials using the juice of almost three dozen beets. When exposed to solutions with a higher pH level, which signals infection, she discovered that a polyester and cotton thread had the optimum combination of thickness, absorbency, and noticeable darkening of color.
Moreover, according to a National Library of Medicine study. The typical pH level of healthy skin is five. Still, the group can rise to around nine when a lesion is infected. Thus, the market is expected to boost in the forecast period from the above statements.
Competitive Landscape
Major key players in the laceration closure devices market are contributing to the market's growth include 3M, Medline Industries, Inc., B. Braun Melsungen AG, Medtronic, Smith & Nephew, Johnson & Johnson, DermaRite Industries, LLC, Stryker, KitoTech Medical, Inc., and Integra LifeSciences Corporation.
3M:
Overview:
The 3M Company is a multinational business specializing in worker safety, health care, and consumer goods in the United States. The four business groups are safety and industrial, transportation and electronics, health care, and consumer items. In addition, 3M received its first patent in 1924 and currently holds around 3,000 patents. In 2014, the firm surpassed the 100,000-patent mark. Furthermore, the company manufactures over 60,000 products under various brands, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical and electronic connecting and insulating materials, medical and car-care products, electronic circuits, healthcare software, and optical films.
Product Portfolio:
3MSteri-Strip Reinforced Adhesive Skin Closures: Steri-Strip Reinforced Skin Closures are used to close lacerations, surgical incisions and follow early suture/staple removal.
Moreover, the company manufactures 3M™ Steri-Strip™ Antimicrobial Skin Closures, 3M™ Steri-Strip™ Blend Tone Skin Closures, and others.
